Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1992 1
1995 1
1996 2
1997 3
1998 2
1999 1
2000 3
2001 6
2002 9
2003 11
2004 12
2005 13
2006 11
2007 17
2008 21
2009 12
2010 24
2011 45
2012 81
2013 81
2014 69
2015 72
2016 75
2017 72
2018 32
2019 18
2020 23
2021 21
2022 19
2023 12
2024 8
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

642 results

Results by year

Filters applied: . Clear all
Page 1
Sipuleucel-T immunotherapy for castration-resistant prostate cancer.
Kantoff PW, Higano CS, Shore ND, Berger ER, Small EJ, Penson DF, Redfern CH, Ferrari AC, Dreicer R, Sims RB, Xu Y, Frohlich MW, Schellhammer PF; IMPACT Study Investigators. Kantoff PW, et al. Among authors: penson df. N Engl J Med. 2010 Jul 29;363(5):411-22. doi: 10.1056/NEJMoa1001294. N Engl J Med. 2010. PMID: 20818862 Free article. Clinical Trial.
Reply by Authors.
Ritch CR, Cookson MS, Clark PE, Chang SS, Fakhoury K, Ralls V, Thu MH, Penson DF, Smith JA Jr, Silver HJ. Ritch CR, et al. Among authors: penson df. J Urol. 2019 Oct;202(4):820. doi: 10.1097/JU.0000000000000375. Epub 2019 Sep 6. J Urol. 2019. PMID: 31166841 No abstract available.
Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer.
Sternberg CN, Fizazi K, Saad F, Shore ND, De Giorgi U, Penson DF, Ferreira U, Efstathiou E, Madziarska K, Kolinsky MP, Cubero DIG, Noerby B, Zohren F, Lin X, Modelska K, Sugg J, Steinberg J, Hussain M; PROSPER Investigators. Sternberg CN, et al. Among authors: penson df. N Engl J Med. 2020 Jun 4;382(23):2197-2206. doi: 10.1056/NEJMoa2003892. Epub 2020 May 29. N Engl J Med. 2020. PMID: 32469184 Clinical Trial.
Editorial Comment.
Penson DF. Penson DF. J Urol. 2018 May;199(5):1232. doi: 10.1016/j.juro.2017.10.073. Epub 2018 Feb 3. J Urol. 2018. PMID: 29406274 No abstract available.
Editorial comment.
Penson DF. Penson DF. J Urol. 2012 Apr;187(4):1398. doi: 10.1016/j.juro.2011.11.119. Epub 2012 Feb 16. J Urol. 2012. PMID: 22341284 No abstract available.
Editorial comment.
Penson DF. Penson DF. J Urol. 2010 May;183(5):1769-70. doi: 10.1016/j.juro.2010.01.095. Epub 2010 Mar 17. J Urol. 2010. PMID: 20299046 No abstract available.
Response.
Hoffman RM, Penson DF. Hoffman RM, et al. Among authors: penson df. J Natl Cancer Inst. 2014 Mar;106(3):djt466. doi: 10.1093/jnci/djt466. Epub 2014 Mar 1. J Natl Cancer Inst. 2014. PMID: 24586103 No abstract available.
Therapeutic Ultrasound and Prostate Cancer.
Sundaram KM, Chang SS, Penson DF, Arora S. Sundaram KM, et al. Among authors: penson df. Semin Intervent Radiol. 2017 Jun;34(2):187-200. doi: 10.1055/s-0037-1602710. Epub 2017 Jun 1. Semin Intervent Radiol. 2017. PMID: 28579687 Free PMC article. Review.
Outcomes research in urology.
Gilbert SM, Penson D. Gilbert SM, et al. Among authors: penson d. World J Urol. 2011 Feb;29(1):1-2. doi: 10.1007/s00345-010-0624-5. Epub 2010 Dec 1. World J Urol. 2011. PMID: 21120504 No abstract available.
642 results